Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?
about
Central nervous system complications after allogeneic hematopoietic stem cell transplantation.Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Thrombotic Microangiopathy and the Kidney.
P2860
Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Is complement blockade an acce ...... ed thrombotic microangiopathy?
@en
type
label
Is complement blockade an acce ...... ed thrombotic microangiopathy?
@en
prefLabel
Is complement blockade an acce ...... ed thrombotic microangiopathy?
@en
P2860
P356
P1476
Is complement blockade an acce ...... ed thrombotic microangiopathy?
@en
P2093
P2860
P2888
P304
P356
10.1038/BMT.2016.253
P407
P577
2016-10-24T00:00:00Z
P6179
1021244152